Sonata Therapeutics
Founded 2022
About Sonata Therapeutics
Sonata Therapeutics is revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact.
Company Facts
- Founded: 2022
- Legal name: Sonata Therapeutics, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Website: sonatatx.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/sonata-therapeutics-8276766 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.